- Home
- BDRX vs IBO Comparison
BDRX vs IBO Comparison
Compare BDRX & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- IBO
- Stock Information
- Founded
- BDRX 2000
- IBO 2018
- Country
- BDRX United Kingdom
- IBO United States
- Employees
- BDRX N/A
- IBO N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- IBO
- Sector
- BDRX Health Care
- IBO
- Exchange
- BDRX Nasdaq
- IBO NYSE
- Market Cap
- BDRX 5.8M
- IBO 5.8M
- IPO Year
- BDRX N/A
- IBO 2024
- Fundamental
- Price
- BDRX $0.90
- IBO $0.76
- Analyst Decision
- BDRX
- IBO
- Analyst Count
- BDRX 0
- IBO 0
- Target Price
- BDRX N/A
- IBO N/A
- AVG Volume (30 Days)
- BDRX 3.2M
- IBO 23.2M
- Earning Date
- BDRX 04-11-2025
- IBO 08-23-2025
- Dividend Yield
- BDRX N/A
- IBO N/A
- EPS Growth
- BDRX N/A
- IBO N/A
- EPS
- BDRX N/A
- IBO N/A
- Revenue
- BDRX N/A
- IBO N/A
- Revenue This Year
- BDRX N/A
- IBO N/A
- Revenue Next Year
- BDRX N/A
- IBO N/A
- P/E Ratio
- BDRX N/A
- IBO N/A
- Revenue Growth
- BDRX N/A
- IBO N/A
- 52 Week Low
- BDRX $0.78
- IBO $0.36
- 52 Week High
- BDRX $41.50
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- BDRX 39.25
- IBO N/A
- Support Level
- BDRX $0.85
- IBO N/A
- Resistance Level
- BDRX $0.97
- IBO N/A
- Average True Range (ATR)
- BDRX 0.11
- IBO 0.00
- MACD
- BDRX -0.00
- IBO 0.00
- Stochastic Oscillator
- BDRX 28.24
- IBO 0.00
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.